Results 41 to 50 of about 2,801 (164)

Advancing Mantle Cell Lymphoma Risk Assessment: Navigating a Moving Target

Hematological Oncology, Volume 43, Issue S2, June 2025.
ABSTRACT Mantle cell lymphoma (MCL) is a B‐cell malignancy characterized by t(11;14)(q13;q32) translocation and heterogeneous clinical behavior. Advances in risk stratification enabled the distinction of conventional MCL (cMCL) from non‐nodal MCL (nnMCL) subtypes, which presents with distinct biological and clinical features.
Simone Ferrero, Simone Ragaini
wiley   +1 more source

Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial

HemaSphere, Volume 10, Issue 1, January 2026.
Simone Ragaini, Elisa Genuardi, Beatrice Alessandria, Aurora Maria Civita, Andrea Evangelista, Daniela Drandi, Carlotta Montana, Sofia Russo, Chiara Consoli, Mariapia Pironti, Stefan Hohaus, Gerardo Musuraca, Nicola Cascavilla, Chiara Ghiggi, Monica Tani, Gianluca Gaidano, Jacopo Olivieri, Sara V. Usai, Nicola Di Renzo, Mario Luppi, Vittorio Stefoni, Federica Cavallo, Marco Ladetto, Simone Ferrero   +23 more
wiley   +1 more source

Enhanced Disease Detection of Hairy Cell Leukaemia Through Next‐Generation Sequencing Based BRAFV600E and Phased Variant Analysis

eJHaem, Volume 6, Issue 3, June 2025.
ABSTRACT Introduction Longitudinal disease assessment by molecular techniques is not routine in hairy cell leukaemia (HCL). Combining BRAFV600E and other genomic targets through next‐generation sequencing (NGS) with phased variant analysis is a novel approach for disease detection in this setting.
Simon Wu, Tamia Nguyen, Imogen Caldwell, Sally Hunter, Sushmitha Kannan, Camille Santos, Yan Zhuang Yap, Clarissa Wilson, Mayani Rawicki, Constantine S. Tam, Rachel Koldej, David Ritchie, Piers Blombery   +12 more
wiley   +1 more source

Adenocarcinoma gástrico metacrónico luego de linfoma gástrico tratado con quimioterapia más radioterapia

Horizonte Médico
El cáncer gástrico ocupa el quinto lugar tanto en incidencia como en mortandad a nivel mundial, según el reporte del Global Cancer Observatory (Globocan) al 2022 (1).
Fernando Barreda Bolaños, Enaida Medrano Palma, Claudia Barreda Velit, Rita Quispe Cordova, Mercedes del Pilar Bravo Taxa   +4 more
doaj   +1 more source

Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in California

Cancer, Volume 131, Issue 9, 1 May 2025.
Abstract Introduction Residence in lower socioeconomic neighborhoods is associated with lower survival in children, adolescents, and young adults with leukemia. We sought to evaluate the impact of neighborhood archetypes on acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) survival.
Lena E. Winestone, Juan Yang, Tanushree Banerjee, Meera Sangaramoorthy, Justine Kahn, Renata Abrahão, Theresa H. Keegan, Iona Cheng, Scarlett Lin Gomez, Salma Shariff‐Marco   +9 more
wiley   +1 more source

TET3 regulates hematopoietic stem cell homeostasis during embryonic and adult hematopoiesis

HemaSphere, Volume 9, Issue 5, May 2025.
ABSTRACT The ten‐eleven translocation family of enzymes (TET1/2/3) promotes DNA demethylation and is essential for hematopoiesis. While the roles of TET1 and TET2 are well‐studied in hematopoiesis, the requirement of TET3 in embryonic and adult hematopoiesis is less investigated.
Harmony C. Ketchum, Claudia Morganti, Chie Yanase, Blake Ebert, Keisuke Ito, Meelad M. Dawlaty   +5 more
wiley   +1 more source

Indirect presentation of mismatched human leukocyte antigen‐B associates with outcomes of cord blood transplantation

British Journal of Haematology, Volume 206, Issue 5, Page 1406-1417, May 2025.
This study analysed 1498 single‐unit cord blood transplantation (CBT) cases (2000–2018) to evaluate the impact of mismatched human leukocyte antigen (HLA) immunogenicity. Results highlighted that Class I epitopes from recipient‐mismatched HLA‐B were associated with higher transplantation‐related mortality (TRM) and lower neutrophil engraftment ...
Takeshi Sugio, Kohta Miyawaki, Naoyuki Uchida, Matthias Niemann, Eric Spierings, Kyohei Mori, Yuju Ohno, Tetsuya Eto, Yasuo Mori, Goichi Yoshimoto, Yoshikane Kikushige, Yuya Kunisaki, Shinichi Mizuno, Koji Nagafuji, Hiromi Iwasaki, Tomohiko Kamimura, Ryosuke Ogawa, Toshihiro Miyamoto, Shuichi Taniguchi, Koichi Akashi, Koji Kato   +20 more
wiley   +1 more source

Linfoma no Hodgkin primario de sistema nervioso central en un paciente pediátrico sin inmunodeficiencia relacionada

Acta Pediátrica de México, 2015
El linfoma no Hodgkin primario de sistema nervioso central es una afección poco frecuente en la población pediátrica. No existen (o son pocas) las recomendaciones o estudios clínicos que sean útiles para definir la mejor opción terapéutica.
Rocío Cárdenas-Cardos, Marco Rodrigo Aguilar-Ortiz, Liliana Velasco-Hidalgo, Pedro Mario Pasquel García-Vázquez, Roberto Rivera-Luna, Alfonso Marhx-Bracho   +5 more
doaj   +1 more source

Linfoma primário de células T no líquido cefalorraquidiano de cão: relato de caso

Arquivo Brasileiro de Medicina Veterinária e Zootecnia, 2012
Relata-se o diagnóstico de linfoma primário no sistema nervoso central em um cão Labrador Retrievier, de 10 anos de idade, que apresentava episódios convulsivos, incoordenação nos membros posteriores, head tilt, ataxia e sensibilidade diminuída no lado ...
L.F. Moraes, F.G. Romão, A.S. Borges, R.K. Takahira, F.B. Souza, R.L. Amorim, L.C. Vulcano   +6 more
doaj   +1 more source

Linfoma canino

Revista de Educação Continuada em Medicina Veterinária e Zootecnia do CRMV-SP, 1999
Apresentam-se neste artigo de revisão, informações básicas sobre linfomas caninos. Descrevem-se, sucintamente, definição, incidência, etiologia, sinais clínicos, estadiamento, classificação morfológica e imunofenotípica, diagnóstico e prognóstico.
Veridiana Maria Brianezi Diagnani De Moura, Júlio Lopes Sequeira, Enio Pedone Bandarra   +2 more
openaire   +2 more sources